18
Oct

Edinburgh, 18th October, 2018 / Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European

17
Oct

Edinburgh, 17th October, 2018 / Synpromics is today unveiling its novel drug-regulatable promoter platform at the

22
Jun
EOY SCOTLAND

Edinburgh, UK, 22nd June 2018 / Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ ca

03
May

Edinburgh, UK, 3rd May 2018 / Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from

23
Apr

Edinburgh, UK, 23rd April 2018 / Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducibl

Pages